Close Menu

NEW YORK – Belgian oncology molecular diagnostics firm Biocartis reported on Thursday that its revenues for the first half of 2020 fell 2 percent year over year.

For the six months ended June 30, Biocartis' total revenues fell to €16.7 million ($19.8 million) from €17.1 million in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.